322 related articles for article (PubMed ID: 16787508)
1. Sex-dimorphic effects of progesterone and its reduced metabolites on gene expression of myelin proteins by rat Schwann cells.
Magnaghi V; Veiga S; Ballabio M; Gonzalez LC; Garcia-Segura LM; Melcangi RC
J Peripher Nerv Syst; 2006 Jun; 11(2):111-8. PubMed ID: 16787508
[TBL] [Abstract][Full Text] [Related]
2. Comparative analysis of Schwann cell lines as model systems for myelin gene transcription studies.
Hai M; Muja N; DeVries GH; Quarles RH; Patel PI
J Neurosci Res; 2002 Aug; 69(4):497-508. PubMed ID: 12210843
[TBL] [Abstract][Full Text] [Related]
3. Progesterone and its derivatives are neuroprotective agents in experimental diabetic neuropathy: a multimodal analysis.
Leonelli E; Bianchi R; Cavaletti G; Caruso D; Crippa D; Garcia-Segura LM; Lauria G; Magnaghi V; Roglio I; Melcangi RC
Neuroscience; 2007 Feb; 144(4):1293-304. PubMed ID: 17187935
[TBL] [Abstract][Full Text] [Related]
4. P0 mRNA expression in cultures of Schwann cells and neurons that lack basal lamina and myelin.
Brunden KR; Brown DT
J Neurosci Res; 1990 Oct; 27(2):159-68. PubMed ID: 1701492
[TBL] [Abstract][Full Text] [Related]
5. Dichloroacetate causes reversible demyelination in vitro: potential mechanism for its neuropathic effect.
Felitsyn N; Stacpoole PW; Notterpek L
J Neurochem; 2007 Jan; 100(2):429-36. PubMed ID: 17241159
[TBL] [Abstract][Full Text] [Related]
6. Temporal expression pattern of peripheral myelin protein 22 during in vivo and in vitro myelination.
Notterpek L; Snipes GJ; Shooter EM
Glia; 1999 Feb; 25(4):358-69. PubMed ID: 10028918
[TBL] [Abstract][Full Text] [Related]
7. Progesterone derivatives are able to influence peripheral myelin protein 22 and P0 gene expression: possible mechanisms of action.
Melcangi RC; Magnaghi V; Cavarretta I; Zucchi I; Bovolin P; D'Urso D; Martini L
J Neurosci Res; 1999 May; 56(4):349-57. PubMed ID: 10340743
[TBL] [Abstract][Full Text] [Related]
8. Peripheral nerves: a target for the action of neuroactive steroids.
Melcangi RC; Cavarretta IT; Ballabio M; Leonelli E; Schenone A; Azcoitia I; Miguel Garcia-Segura L; Magnaghi V
Brain Res Brain Res Rev; 2005 Apr; 48(2):328-38. PubMed ID: 15850671
[TBL] [Abstract][Full Text] [Related]
9. Coexpression of PMP22 gene with MBP and P0 during de novo myelination and nerve repair.
Kuhn G; Lie A; Wilms S; Müller HW
Glia; 1993 Aug; 8(4):256-64. PubMed ID: 7691737
[TBL] [Abstract][Full Text] [Related]
10. Increased P0 glycoprotein gene expression in primary and transfected rat Schwann cells after treatment with axolemma-enriched fraction.
Knight RM; Fossom LH; Neuberger TJ; Attema BL; Tennekoon G; Bharucha V; DeVries GH
J Neurosci Res; 1993 May; 35(1):38-45. PubMed ID: 7685396
[TBL] [Abstract][Full Text] [Related]
11. GABAB receptors in Schwann cells influence proliferation and myelin protein expression.
Magnaghi V; Ballabio M; Cavarretta IT; Froestl W; Lambert JJ; Zucchi I; Melcangi RC
Eur J Neurosci; 2004 May; 19(10):2641-9. PubMed ID: 15147298
[TBL] [Abstract][Full Text] [Related]
12. Expression of myelin protein gene transcripts by Schwann cells of regenerating nerve.
Mitchell LS; Griffiths IR; Morrison S; Barrie JA; Kirkham D; McPhilemy K
J Neurosci Res; 1990 Oct; 27(2):125-35. PubMed ID: 1701490
[TBL] [Abstract][Full Text] [Related]
13. Neuroactive steroids and peripheral myelin proteins.
Magnaghi V; Cavarretta I; Galbiati M; Martini L; Melcangi RC
Brain Res Brain Res Rev; 2001 Nov; 37(1-3):360-71. PubMed ID: 11744100
[TBL] [Abstract][Full Text] [Related]
14. Shear stress alters the expression of myelin-associated glycoprotein (MAG) and myelin basic protein (MBP) in Schwann cells.
Gupta R; Truong L; Bear D; Chafik D; Modafferi E; Hung CT
J Orthop Res; 2005 Sep; 23(5):1232-9. PubMed ID: 16140204
[TBL] [Abstract][Full Text] [Related]
15. Structure and expression of proteolipid protein in the peripheral nervous system.
Kamholz J; Sessa M; Scherer S; Vogelbacker H; Mokuno K; Baron P; Wrabetz L; Shy M; Pleasure D
J Neurosci Res; 1992 Feb; 31(2):231-44. PubMed ID: 1374129
[TBL] [Abstract][Full Text] [Related]
16. JNK1 activation mediates C5b-9-induced P0 mRNA instability and P0 gene expression in Schwann cells.
David S; Hila S; Fosbrink M; Rus H; Koski CL
J Peripher Nerv Syst; 2006 Mar; 11(1):77-87. PubMed ID: 16519786
[TBL] [Abstract][Full Text] [Related]
17. Myelin basic protein gene dosage effects in the PNS.
Smith-Slatas C; Barbarese E
Mol Cell Neurosci; 2000 Apr; 15(4):343-54. PubMed ID: 10845771
[TBL] [Abstract][Full Text] [Related]
18. Mitochondrial schwannopathy and peripheral myelinopathy in a rabbit model of dideoxycytidine neurotoxicity.
Anderson TD; Davidovich A; Feldman D; Sprinkle TJ; Arezzo J; Brosnan C; Calderon RO; Fossom LH; DeVries JT; DeVries GH
Lab Invest; 1994 May; 70(5):724-39. PubMed ID: 7515130
[TBL] [Abstract][Full Text] [Related]
19. Modulation of Schwann cell phenotype by TGF-beta 1: inhibition of P0 mRNA expression and downregulation of the low affinity NGF receptor.
Mews M; Meyer M
Glia; 1993 Jul; 8(3):208-17. PubMed ID: 7693590
[TBL] [Abstract][Full Text] [Related]
20. The alpha-chemokine CXCL14 is up-regulated in the sciatic nerve of a mouse model of Charcot-Marie-Tooth disease type 1A and alters myelin gene expression in cultured Schwann cells.
Barbaria EM; Kohl B; Buhren BA; Hasenpusch-Theil K; Kruse F; Küry P; Martini R; Müller HW
Neurobiol Dis; 2009 Mar; 33(3):448-58. PubMed ID: 19111616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
